REQUEST A DEMO
Total
USD $0.00
Search more companies

Pharmatek Ecza Deposu Tibbi Urunler A.S. (Turkiye)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Pharmatek Ecza Deposu Tibbi Urunler Anonim Sirketi Profile Updated: December 12, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Pharmatek Ecza Deposu Tibbi Urunler A.S. is an enterprise located in Turkiye, with the main office in Ankara. The enterprise currently operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. Pharmatek Ecza Deposu Tibbi Urunler A.S. currently employs 15 (2023) people. In 2022, the company reported a net sales revenue increase of 422.79%. During that time, Pharmatek Ecza Deposu Tibbi Urunler A.S.’s total assets grew by 374.71%. In 2022, Pharmatek Ecza Deposu Tibbi Urunler A.S.’s net profit margin increased by 0.12%.

Headquarters
No:14 A Turgut Ozal Mahallesi 2177.cadde Yenimahalle
Ankara; Central Anatolia; Postal Code: 06370

Contact Details: Purchase the Pharmatek Ecza Deposu Tibbi Urunler A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Pharmatek Ecza Deposu Tibbi Urunler A.S. report to view the information.
Outstanding Shares:
Purchase the Pharmatek Ecza Deposu Tibbi Urunler A.S. report to view the information.
Incorporation Date:
Key Executives
Purchase this report to view the information.
Chairman
Company Performance
Financial values in the chart are available after Pharmatek Ecza Deposu Tibbi Urunler A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TRY. Absolute financial data is included in the purchased report.
Net sales revenue
422.79%
Total operating revenue
422.79%
Operating profit (EBIT)
105.74%
Net Profit (Loss) for the Period
500.73%
Total assets
374.71%
Total equity
5560.83%
Operating Profit Margin (ROS)
-2.39%
Net Profit Margin
0.12%
Return on Equity (ROE)
-32.71%
Debt to Equity Ratio
-372.45%
Quick Ratio
0.3%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?